Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2016

Dec 5, 2016

30870_dirs_2016-12-05_13a5dec9-8020-4507-8045-c9e4a7407fed.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2016-12-01

Reporting Person: Schnieders Elisabeth (Sr. VP, Business Development)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 16485 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Incentive Stock Option (right to buy) $6.0 2023-03-05 Common Stock (21163) Direct
Incentive Stock Option (right to buy) $6.3 2022-03-05 Common Stock (14990) Direct
Incentive Stock Option (right to buy) $6.67 2026-02-23 Common Stock (14442) Direct
Incentive Stock Option (right to buy) $7.96 2025-02-26 Common Stock (11043) Direct
Incentive Stock Option (right to buy) $9.42 2021-02-28 Common Stock (12500) Direct
Incentive Stock Option (right to buy) $9.65 2024-02-24 Common Stock (18419) Direct
Incentive Stock Option (right to buy) $11.1 2019-02-26 Common Stock (3866) Direct
Incentive Stock Option (right to buy) $18.48 2020-02-24 Common Stock (8666) Direct
Incentive Stock Option (right to buy) $20.22 2018-02-28 Common Stock (2500) Direct
Incentive Stock Option (right to buy) $40.86 2017-03-14 Common Stock (2000) Direct
Non-Qualified Stock Option (right to buy) $6.0 2023-03-05 Common Stock (3836) Direct
Non-Qualified Stock Option (right to buy) $6.3 2022-03-05 Common Stock (9) Direct
Non-Qualified Stock Option (right to buy) $6.67 2026-02-23 Common Stock (20558) Direct
Non-Qualified Stock Option (right to buy) $7.96 2025-02-26 Common Stock (18957) Direct
Non-Qualified Stock Option (right to buy) $9.65 2024-02-24 Common Stock (11581) Direct

Footnotes

F1: When the ISO and NQ dated 03/05/2013 are combined for a total grant of 24,999 shares, the option shall vest and become exercisable as to 24,999 shares divided into equal monthly installments such that the option shall be 100% vested on 03/05/2017.

F2: When the ISO and NQ dated 03/05/2012 are combined for a total grant of 14,999 shares, the option vested and became exercisable as to 14,999 shares divided into equal monthly installments such that the option was 100% vested on 03/05/2016.

F3: When the ISO and NQ dated 02/23/2016 are combined for a total grant of 35,000 shares, the option shall vest and become exercisable as to 35,000 shares divided into equal monthly installments such that the option shall be 100% vested on 02/23/2020.

F4: When the ISO and NQ dated 02/26/2015 are combined for a total grant of 30,000 shares, the option shall vest and become exercisable as to 30,000 shares divided into equal monthly installments such that the option shall be 100% vested on 02/26/2019.

F5: This option vested and became exercisable as to 12,500 shares divided into equal monthly installments and became fully vested on 02/28/2015.

F6: When the ISO and NQ dated 02/24/2014 are combined for a total grant of 30,000 shares, the option shall vest and become exercisable as to 30,000 shares divided into equal monthly installments such that the option shall be 100% vested on 02/24/2018.

F7: This option vested and became exercisable as to 3,866 shares divided into equal monthly installments such that the option was 100% vested on 02/26/2013.

F8: This option vested and became exercisable as to 8,666 shares divided into equal monthly installments such that the option was 100% vested on 02/24/2014.

F9: This option vested and became exercisable as to 2,500 shares divided into equal monthly installments and became fully vested on 02/29/2012.

F10: This option vested and became exercisable as to 2,000 shares divided into equal monthly installments and became fully vested on 03/01/2011.